Directory

>

Andy Stadheim

avatar

Andy Stadheim

Vice President | Entrada Therapeutics

Boston, Massachusetts, United States

View contact details (it's free)

Andy Stadheim

Summary

Andy Stadheim is a seasoned biotechnology executive currently serving as Vice President at Entrada Therapeutics in Boston. With extensive experience spanning over two decades in the biotech and pharmaceutical industries, he has a strong background in analytical chemistry, biochemistry, and drug development. Andy has demonstrated exceptional leadership in managing cross-functional teams and fostering research collaborations. His educational credentials include a PhD in Pharmacology and an MBA, equipping him with both scientific and business acumen. He has previously held senior roles at notable companies like Novo Nordisk and Merck, where he contributed to significant advancements in biologics and oligonucleotide therapies. Passionate about innovation in life sciences, Andy is committed to leveraging his expertise to drive impactful healthcare solutions. His journey reflects a blend of technical proficiency and strategic insight, making him a valuable asset in the biotechnology landscape.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Andy Stadheim

Work Experience

company logo

Vice President at

Entrada Therapeutics

January 2021 - Present

company logo

Head of Product Development / Antibody Discovery at

Entrada Therapeutics

January 2020 - January 2021

company logo

Senior Manager, Quality Control at

Novo Nordisk

January 2017 - January 2020

company logo

Director at

Celdara Medical

January 2016 - January 2017

company logo

Director- Molecular Discovery at

Merck

January 2012 - January 2016

💼

Director Strain Development and High Throughput Screening at

GlycoFi

August 2008 - January 2012

💼

Associate Director High Throughput Screening at

GlycoFi

February 2008 - August 2008

💼

Associate Director Analytical Development at

GlycoFi

March 2006 - February 2008

💼

Senior Scientist at

GlycoFi

August 2005 - February 2006

💼

Scientist II at

GlycoFi

December 2003 - August 2005

💼

Scientist I at

GlycoFi

December 2002 - December 2003

💼

Postdoc at

GlycoFi

September 2002 - December 2002

Logos provided by Logo.dev

Andy Stadheim

Education

Dartmouth College, Postdoc

January 1999 - January 2002

Wake Forest University, Phd

January 1994 - January 1998

Virginia Tech MBA, Bs

January 1991 - January 1994

James Madison University

January 1990 - January 1991

Frequently Asked Questions about Andy Stadheim

What is Andy Stadheim email address?

Andy Stadheim's primary email address is *********@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Andy Stadheim work for?

Andy Stadheim is a Vice President at Entrada Therapeutics, a company specializing in Commercial physical research.

Where Andy Stadheim graduated from?

Andy Stadheim holds a degree in Merck Emerging Leaders Program from Harvard Business School Executive Education.

How can I directly contact Andy Stadheim?

To contact Andy Stadheim directly, you can use the email address *********@entradatx.com. Complete contact information is available upon registration with Muraena.

Who is Andy Stadheim?

Andy Stadheim is a seasoned biotechnology executive currently serving as Vice President at Entrada Therapeutics in Boston. With extensive experience spanning over two decades in the biotech and pharmaceutical industries, he has a strong background in analytical chemistry, biochemistry, and drug development. Andy has demonstrated exceptional leadership in managing cross-functional teams and fostering research collaborations. His educational credentials include a PhD in Pharmacology and an MBA, equipping him with both scientific and business acumen. He has previously held senior roles at notable companies like Novo Nordisk and Merck, where he contributed to significant advancements in biologics and oligonucleotide therapies. Passionate about innovation in life sciences, Andy is committed to leveraging his expertise to drive impactful healthcare solutions. His journey reflects a blend of technical proficiency and strategic insight, making him a valuable asset in the biotechnology landscape.

Andy`s contact details

mail

*********@entradatx.com

Colleagues

avatar
Ray Shiao

Executive Director, FP&A

Steven Leili

Executive Director

avatar
Sweta Girgenrath

Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics

avatar
Kory Wentworth

Chief Financial Officer and Treasurer

avatar
Kush Parmar D

Board Member

avatar
Leo Qian

Co-Founder & Vice President, Discovery Research

avatar
Murali Mallem

Vice President | Head of CMC

avatar
Natarajan Sethuraman

President Research And Development at Entrada Therapeutics

avatar
Nathan Dowden

President and Chief Operating Officer

avatar
Katie Darius

VP, Program Governance & Portfolio Management

View Contact details (it's free)
Request Profile Removal